Which has the lower trailing P/E, ADUS or AUPH?

AUPH has the lower trailing P/E: ADUS trades at 19.76 and AUPH at 6.83. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ADUS or AUPH?

Over the past five years, AUPH grew revenue faster — ADUS at a 12.67% CAGR versus AUPH at 40.17%.

Is ADUS or AUPH more profitable?

AUPH runs the higher net margin — ADUS at 7.13% versus AUPH at 100.84%.

How have ADUS and AUPH total returns compared?

Over the past 10 years, ADUS delivered 15.62% and AUPH delivered 14.53% annualized total return. Past performance doesn't predict future results.

Addus HomeCare Corporation (ADUS) vs Aurinia Pharmaceuticals Inc. (AUPH)

A side-by-side comparison of Addus HomeCare Corporation and Aurinia Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADUS

Addus HomeCare Corporation

$2.10B

$112.63HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT

AUPH

Aurinia Pharmaceuticals Inc.

$2.01B

$15.64HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — ADUS vs AUPH

growth of $100 · dividends reinvested · last 10y

ADUS +333.9% (+15.8%/yr)AUPH +288.1% (+14.5%/yr)ADUS compounded faster over this window

ADUS AUPH

ADUS vs AUPH: by the numbers

•ADUS is the larger company ($2.10B vs $2.01B market cap).
•AUPH trades at the lower trailing earnings multiple (6.83 vs 19.76 P/E), one valuation lens rather than an overall verdict.
•AUPH converts more revenue to profit (100.84% vs 7.13% net margin).
•AUPH grew revenue faster over the past five years (40.17% vs 12.67% CAGR).

Metrics side by side

Valuation

Metric	ADUS	AUPH
P/E ratio	19.76	6.83
Forward P/E	15.98	16.56
PEG ratio	0.98	N/A
P/S ratio	1.42	6.45
P/B ratio	1.83	3.27
EV / EBITDA	12.80	11.12
FCF yield	7.28%	8.63%

Profitability

Metric	ADUS	AUPH
Gross margin	32.36%	90.36%
Operating margin	10.04%	37.06%
Net margin	7.13%	100.84%
ROE	9.17%	51.09%
ROIC	8.61%	21.77%

Growth (annualized)

Metric	ADUS	AUPH
Revenue CAGR (5Y)	12.67%	40.17%
EPS CAGR (5Y)	19.61%	N/A
FCF CAGR (5Y)	24.41%	N/A
Total return CAGR (5Y)	8.33%	-5.88%

Frequently asked

Which has the lower trailing P/E, ADUS or AUPH?: AUPH has the lower trailing P/E: ADUS trades at 19.76 and AUPH at 6.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ADUS or AUPH?: Over the past five years, AUPH grew revenue faster — ADUS at a 12.67% CAGR versus AUPH at 40.17%.
Is ADUS or AUPH more profitable?: AUPH runs the higher net margin — ADUS at 7.13% versus AUPH at 100.84%.
How have ADUS and AUPH total returns compared?: Over the past 10 years, ADUS delivered 15.62% and AUPH delivered 14.53% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADUS analysis Full AUPH analysis Interactive comparison tool

Dig into the metrics

Addus HomeCare P/E ratio Aurinia Pharmaceuticals P/E ratio Addus HomeCare ROE Aurinia Pharmaceuticals ROE Addus HomeCare operating margin Aurinia Pharmaceuticals operating margin Addus HomeCare revenue growth Aurinia Pharmaceuticals revenue growth Addus HomeCare free cash flow Aurinia Pharmaceuticals free cash flow

Addus HomeCare & Aurinia Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.